SES to Participate in Seed Fund with Luxembourg Government to Finance ICT Start-Ups
SES S.A. (NYSE Paris:SESG) (LuxX:SESG) announced today the signature of a letter of commitment with the Luxembourg Government and six other partners to finance ICT start-ups.
The initiative taken by the Ministry of the Economy in the context of « Digital Lëtzebuerg » seeks to set up an ecosystem that fully adapts to the needs of start-ups within the ICT sector, while offering an adequate framework for the creation and development of young and innovative companies - an ecosystem that adapts to the needs of ICT start-ups, in particular in terms of financing such companies in the early stages of development.
The signing parties agreed to collect public and private funds worth EUR 19.2 million to create a seed fund-type structure designed to finance innovative technology companies within the ICT sector.
Above all but not exclusively, the fund will create risk capital investments within projects that have reached “proof of concept” in the domains of cybersecurity, FinTech, Big Data, Digital Health, Internet of Things and satellite telecommunications, for example. In order to facilitate transferring new technologies stemming from public research and, in particular, from the Luxembourg University Interdisciplinary Centre for Security, Reliability and Trust (SnT), the seed fund’s objective also lies in investing in promising spin-offs in order to maximize the national economic benefits.
The future ICT seed fund has been developed in the context of a Public Private Partnership, involving renowned participants from the world of finance and economics. The capital fund will be operational as of the beginning of 2016 and managed by a specialised team that has the necessary skills to best identify and select innovative business projects showing a strong development potential in Luxembourg.
Besides SES, the other partners are Arendt & Medernach, BHS Invest, BIL, État Luxembourgeois, POST Capital, Proximus and SNCI.
Follow us on:
SES Pictures are available under http://www.ses.com/21472913/Our_Pictures
SES White papers are available under http://www.ses.com/18681915/white-papers
SES (NYSE Paris:SESG) (LuxX:SESG) is the world-leading satellite operator with a fleet of more than 50 geostationary satellites. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators and business and governmental organisations worldwide.
SES stands for long-lasting business relationships, high-quality service and excellence in the satellite industry. The culturally diverse regional teams of SES are located around the globe and work closely with customers to meet their specific satellite bandwidth and service requirements.
SES holds a participation in O3b Networks, a next generation satellite network combining the reach of satellite with the speed of fibre.
Further information available at: www.ses.com .
Tel. +352 710 725 500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum